Nicolas Sayegh

1.8k total citations
68 papers, 527 citations indexed

About

Nicolas Sayegh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Nicolas Sayegh has authored 68 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Nicolas Sayegh's work include Prostate Cancer Treatment and Research (36 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Renal cell carcinoma treatment (16 papers). Nicolas Sayegh is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Renal cell carcinoma treatment (16 papers). Nicolas Sayegh collaborates with scholars based in United States, Canada and Mexico. Nicolas Sayegh's co-authors include Neeraj Agarwal, Umang Swami, Nishita Tripathi, Georges Gebrael, Benjamin L. Maughan, Vinay Mathew Thomas, Roberto Nussenzveig, Kamal Kant Sahu, Mei Yee Koh and Deepika Sirohi and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Nicolas Sayegh

57 papers receiving 524 citations

Peers

Nicolas Sayegh
Sarah Jo Stephens United States
Sennett K. Kim United States
Angela Y. Jia United States
Vinay Mathew Thomas United States
Nishita Tripathi United States
Nathan C. Nussbaum United States
Nityam Rathi United States
Tyler F. Stewart United States
Sarah Jo Stephens United States
Nicolas Sayegh
Citations per year, relative to Nicolas Sayegh Nicolas Sayegh (= 1×) peers Sarah Jo Stephens

Countries citing papers authored by Nicolas Sayegh

Since Specialization
Citations

This map shows the geographic impact of Nicolas Sayegh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Sayegh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Sayegh more than expected).

Fields of papers citing papers by Nicolas Sayegh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Sayegh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Sayegh. The network helps show where Nicolas Sayegh may publish in the future.

Co-authorship network of co-authors of Nicolas Sayegh

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Sayegh. A scholar is included among the top collaborators of Nicolas Sayegh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Sayegh. Nicolas Sayegh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graf, Ryon P., Nicolas Sayegh, Gerald Li, et al.. (2025). Association of Homologous Recombination Repair Alterations with Outcomes in Patients with Metastatic Hormone-Sensitive Prostate Cancer. Clinical Cancer Research. 31(19). 4101–4109.
2.
Gebrael, Georges, Nicolas Sayegh, Tony Crispino, et al.. (2025). A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors. CA A Cancer Journal for Clinicians. 75(2). 141–167. 11 indexed citations
3.
Gebrael, Georges, et al.. (2025). T-cell Engagers in Prostate Cancer. European Urology. 87(5). 553–558. 2 indexed citations
4.
Swami, Umang, Yeonjung Jo, Nicolas Sayegh, et al.. (2025). Real-world use of bone-modifying agents (BMA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the US.. Journal of Clinical Oncology. 43(5_suppl). 95–95.
5.
Thomas, Vinay Mathew, Georges Gebrael, Nicolas Sayegh, et al.. (2024). Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI. JCO Precision Oncology. 8(8). e2300574–e2300574. 1 indexed citations
8.
Gebrael, Georges, Nicolas Sayegh, Nishita Tripathi, et al.. (2024). Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting. The Prostate. 84(9). 888–892. 1 indexed citations
9.
Li, Haoran, Kamal Kant Sahu, Nishita Tripathi, et al.. (2023). Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas. Cancers. 15(21). 5171–5171. 1 indexed citations
10.
Sayegh, Nicolas, Umang Swami, Yeonjung Jo, et al.. (2023). Race and Treatment Outcomes in Patients With Metastatic Castration-Sensitive Prostate Cancer. JAMA Network Open. 6(8). e2326546–e2326546. 5 indexed citations
11.
Chehrazi‐Raffle, Alex, Xiaochen Li, Zeynep Büşra Zengin, et al.. (2023). Real-World Outcomes of Latinx Versus Non-Latinx Patients Treated With First-Line Immunotherapy for Metastatic Renal-Cell Carcinoma. The Oncologist. 28(12). 1079–1084. 1 indexed citations
12.
Agarwal, Neeraj, Tian Zhang, Eleni Efstathiou, et al.. (2023). The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer. European Journal of Cancer. 192. 113249–113249. 21 indexed citations
14.
Swami, Umang, Nicolas Sayegh, Yeonjung Jo, et al.. (2022). External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer. Molecular Cancer Therapeutics. 21(12). 1857–1861. 5 indexed citations
15.
Graham, Jeffrey, J. Connor Wells, Shaan Dudani, et al.. (2022). Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy. European Journal of Cancer. 171. 124–132. 20 indexed citations
16.
Sahu, Kamal Kant, Nicolas Sayegh, Nishita Tripathi, et al.. (2022). A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers. Heliyon. 8(9). e10583–e10583. 2 indexed citations
17.
Chawla, Neal Shiv, Nicolas Sayegh, Nishita Tripathi, et al.. (2022). Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors. Clinical Genitourinary Cancer. 21(1). 69–75. 7 indexed citations
18.
McFarland, Taylor Ryan, Vinay Mathew Thomas, Roberto Nussenzveig, et al.. (2022). Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting. Biomedicines. 10(12). 3170–3170. 2 indexed citations
19.
Swami, Umang, Ryon P. Graf, Roberto Nussenzveig, et al.. (2022). SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical Cancer Research. 28(22). 4917–4925. 40 indexed citations
20.
Lin, Edwin, Andrew W. Hahn, Roberto Nussenzveig, et al.. (2021). Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. The Oncologist. 26(9). 751–760. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026